MA27059A1 - Azithromycine en dose unique - Google Patents
Azithromycine en dose uniqueInfo
- Publication number
- MA27059A1 MA27059A1 MA27523A MA27523A MA27059A1 MA 27059 A1 MA27059 A1 MA 27059A1 MA 27523 A MA27523 A MA 27523A MA 27523 A MA27523 A MA 27523A MA 27059 A1 MA27059 A1 MA 27059A1
- Authority
- MA
- Morocco
- Prior art keywords
- azithromycin
- single dose
- priorities
- august
- abstract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
DEPOSANT Société dite: PFIZER PRODUCTS INC. REVENDICATION DE PRIORITES us 21 Août 2001 60/313,867 Voir en annexe le titre de l'invention et le texte de l'abrégé "Azithromycine en dose unique" La présente invention concerne une méthode de traitement d'infections respiratoires chez l'homme en administrant une dose unique d'azithromycine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31386701P | 2001-08-21 | 2001-08-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27059A1 true MA27059A1 (fr) | 2004-12-20 |
Family
ID=23217490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA27523A MA27059A1 (fr) | 2001-08-21 | 2004-02-11 | Azithromycine en dose unique |
Country Status (25)
Country | Link |
---|---|
US (3) | US20030148964A1 (fr) |
EP (1) | EP1418924A2 (fr) |
JP (1) | JP2005501862A (fr) |
KR (1) | KR20040032942A (fr) |
AP (1) | AP1729A (fr) |
BG (1) | BG108537A (fr) |
BR (1) | BR0211830A (fr) |
CA (1) | CA2458135A1 (fr) |
CZ (1) | CZ2004232A3 (fr) |
EA (1) | EA200400214A1 (fr) |
EC (1) | ECSP044985A (fr) |
GE (1) | GEP20063812B (fr) |
HR (1) | HRP20040163A2 (fr) |
HU (1) | HUP0401332A2 (fr) |
IL (1) | IL159585A0 (fr) |
IS (1) | IS7092A (fr) |
MA (1) | MA27059A1 (fr) |
MX (1) | MXPA04001605A (fr) |
OA (1) | OA12845A (fr) |
PL (1) | PL367888A1 (fr) |
SK (1) | SK1012004A3 (fr) |
TN (1) | TNSN04035A1 (fr) |
WO (1) | WO2003018031A2 (fr) |
YU (1) | YU8804A (fr) |
ZA (1) | ZA200400804B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7572773B2 (en) * | 2003-07-24 | 2009-08-11 | Pliva Hrvatska D.O.O. | Single dose fast dissolving azithromycin |
EP1691787B1 (fr) | 2003-12-04 | 2008-07-02 | Pfizer Products Inc. | Procédé de fabrication de formes pharmaceutiques multiparticulaires |
BRPI0416534A (pt) | 2003-12-04 | 2007-01-09 | Pfizer Prod Inc | composições multiparticuladas com estabilidade melhorada |
US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
HUE029994T2 (en) | 2005-12-08 | 2017-04-28 | Insmed Inc | Lipid-based preparations of antinfectants for the treatment of lung infections |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US20090005326A1 (en) * | 2007-06-26 | 2009-01-01 | Idexx Laboratories, Inc. | Single dose roxithromycin |
US20090197956A1 (en) * | 2008-02-04 | 2009-08-06 | Arbor Pharmaceuticals, Inc. | Treatment of acute otitis media with xylitol and n-acetylcysteine |
US20110105421A1 (en) * | 2008-03-14 | 2011-05-05 | The Florida International University Board Of Trustees | Ellagitannins as inhibitors of bacterial quorum sensing |
US20130156803A1 (en) | 2011-06-04 | 2013-06-20 | Rochester General Hospital Research Institute | Compositions and methods related to p6 |
BR112015012351A8 (pt) | 2012-11-29 | 2019-10-01 | Insmed Inc | composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
JP7460534B2 (ja) | 2018-03-30 | 2024-04-02 | インスメッド インコーポレイテッド | リポソーム医薬品の連続製造方法 |
EP4103725A4 (fr) * | 2020-02-14 | 2024-03-27 | Asklepios Biopharmaceutical, Inc. | Procédé de traitement d'une toxicité associée à une thérapie génique avec des antibiotiques |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US53264A (en) * | 1866-03-20 | Improved ditching-machine | ||
SI7910768A8 (en) * | 1979-04-02 | 1996-06-30 | Pliva Pharm & Chem Works | Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives |
SI8110592A8 (en) * | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
UA27040C2 (uk) * | 1987-07-09 | 2000-02-28 | Пфайзер Інк. | Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу |
WO1989002271A1 (fr) * | 1987-09-10 | 1989-03-23 | Pfizer | Azithromycine et derives utilises comme agents anti-protozoaires |
YU45590A (sh) * | 1990-03-07 | 1992-07-20 | PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. | Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje |
TW271400B (fr) * | 1992-07-30 | 1996-03-01 | Pfizer | |
ATE154806T1 (de) * | 1993-05-19 | 1997-07-15 | Pfizer | Zwischenprodukt für azithromycin |
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
JP2977907B2 (ja) * | 1994-05-06 | 1999-11-15 | ファイザー・インコーポレーテッド | アジスロマイシンの放出調節された剤形 |
HRP980189B1 (en) * | 1998-04-06 | 2004-04-30 | Pliva Pharm & Chem Works | Novel 15-membered lactams ketolides |
US6239113B1 (en) * | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
US20040053264A1 (en) * | 2002-02-01 | 2004-03-18 | Park Sung Sup | Clinical panel assay using DNA chips |
-
2002
- 2002-07-31 SK SK101-2004A patent/SK1012004A3/sk not_active Application Discontinuation
- 2002-07-31 PL PL02367888A patent/PL367888A1/xx not_active Application Discontinuation
- 2002-07-31 IL IL15958502A patent/IL159585A0/xx unknown
- 2002-07-31 CA CA002458135A patent/CA2458135A1/fr not_active Abandoned
- 2002-07-31 WO PCT/IB2002/003076 patent/WO2003018031A2/fr not_active Application Discontinuation
- 2002-07-31 JP JP2003522549A patent/JP2005501862A/ja active Pending
- 2002-07-31 KR KR10-2004-7002492A patent/KR20040032942A/ko not_active Application Discontinuation
- 2002-07-31 GE GE5411A patent/GEP20063812B/en unknown
- 2002-07-31 EA EA200400214A patent/EA200400214A1/ru unknown
- 2002-07-31 YU YU8804A patent/YU8804A/sh unknown
- 2002-07-31 BR BR0211830-0A patent/BR0211830A/pt not_active IP Right Cessation
- 2002-07-31 OA OA1200400048A patent/OA12845A/en unknown
- 2002-07-31 HU HU0401332A patent/HUP0401332A2/hu unknown
- 2002-07-31 MX MXPA04001605A patent/MXPA04001605A/es active IP Right Grant
- 2002-07-31 EP EP02753170A patent/EP1418924A2/fr not_active Withdrawn
- 2002-07-31 CZ CZ2004232A patent/CZ2004232A3/cs unknown
- 2002-07-31 AP APAP/P/2004/002968A patent/AP1729A/en active
- 2002-08-21 US US10/224,903 patent/US20030148964A1/en not_active Abandoned
-
2003
- 2003-07-25 US US10/628,102 patent/US6987093B2/en not_active Expired - Fee Related
- 2003-12-23 IS IS7092A patent/IS7092A/is unknown
-
2004
- 2004-01-21 BG BG108537A patent/BG108537A/bg unknown
- 2004-01-30 ZA ZA200400804A patent/ZA200400804B/en unknown
- 2004-02-11 MA MA27523A patent/MA27059A1/fr unknown
- 2004-02-19 HR HR20040163A patent/HRP20040163A2/xx not_active Application Discontinuation
- 2004-02-20 TN TNP2004000035A patent/TNSN04035A1/fr unknown
- 2004-02-20 EC EC2004004985A patent/ECSP044985A/es unknown
-
2005
- 2005-06-29 US US11/172,012 patent/US7067493B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20050250712A1 (en) | 2005-11-10 |
US7067493B2 (en) | 2006-06-27 |
US20030148964A1 (en) | 2003-08-07 |
AP1729A (en) | 2007-03-26 |
PL367888A1 (en) | 2005-03-07 |
US20040023898A1 (en) | 2004-02-05 |
IS7092A (is) | 2003-12-23 |
CA2458135A1 (fr) | 2003-03-06 |
MXPA04001605A (es) | 2004-07-08 |
TNSN04035A1 (fr) | 2006-06-01 |
HUP0401332A2 (hu) | 2004-11-29 |
CZ2004232A3 (cs) | 2005-10-12 |
IL159585A0 (en) | 2004-06-01 |
HRP20040163A2 (en) | 2005-02-28 |
WO2003018031A3 (fr) | 2003-10-02 |
AP2004002968A0 (en) | 2004-03-31 |
EA200400214A1 (ru) | 2004-06-24 |
EP1418924A2 (fr) | 2004-05-19 |
KR20040032942A (ko) | 2004-04-17 |
ZA200400804B (en) | 2005-05-03 |
JP2005501862A (ja) | 2005-01-20 |
BR0211830A (pt) | 2004-09-08 |
SK1012004A3 (sk) | 2005-04-01 |
US6987093B2 (en) | 2006-01-17 |
WO2003018031A2 (fr) | 2003-03-06 |
GEP20063812B (en) | 2006-05-10 |
ECSP044985A (es) | 2004-04-28 |
OA12845A (en) | 2006-09-15 |
YU8804A (sh) | 2006-08-17 |
BG108537A (bg) | 2005-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27059A1 (fr) | Azithromycine en dose unique | |
EE200400020A (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
YU1097A (sh) | 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni | |
YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
MXPA03005340A (es) | Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida. | |
TW200510343A (en) | Substituted dihydroquinazolines | |
GB9902555D0 (en) | Medicament | |
MXPA04005156A (es) | Antagonistas del receptor de adenosina a2a. | |
GB0111186D0 (en) | Novel compounds | |
MXPA03010549A (es) | Formas de dosificacion de oxcarbazepina. | |
EP1037650A4 (fr) | Procedes et compositions pour le traitement et la prevention d'infections a staphylococcus aureus | |
TW200510449A (en) | Acylated nonadepsipeptides | |
DK1057828T3 (da) | Orale trovafloxacin-suspensioner | |
EA200400436A1 (ru) | Медикаменты для профилактики и лечения бромидроза | |
AU2003210850A8 (en) | N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof | |
BRPI0414139A (pt) | métodos e composições para tratar infecções por herpes | |
AU1604592A (en) | New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments | |
WO2003024996A3 (fr) | Macrocycles antibacteriens | |
PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados | |
DE50202865D1 (de) | Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel | |
HUP0202888A2 (hu) | Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény | |
WO2005121160A3 (fr) | Agents antibacteriens macrolides de thiocarbamate cyclique 11,12 | |
BR0007491A (pt) | Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções | |
ATE212839T1 (de) | Hämoregulatorische verbindungen |